Psychedelic Stocks Index Soared 27% On Monday

31 biopharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues. 15 of them are constituents in the Psychedelic Stocks Index and this article highlights their performances.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.